PA
HALO icon

Procyon Advisors’s Halozyme HALO Stock Holding History

Procyon Advisors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,625
Closed -$295K – 537
2025
Q1 		$295K Buy
4,625
+154
+3% +$8.95K 0.02% 488
2024
Q4 		$214K Sell
4,471
-975
-18% -$50K 0.01% 516
2024
Q3 		$312K Sell
5,446
-820
-13% -$47K 0.02% 442
2024
Q2 		$328K Buy
+6,266
New +$275K 0.02% 401

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Procyon Advisors's HALO Position: Q2 2025 in Review

Procyon Advisors sold out of Halozyme (HALO) in Q2 2025, closing a stake of 4,625 shares — an estimated $295K sold.

Procyon Advisors first reported a position in HALO in Q2 2024 and held it in 4 quarters. The position peaked at $328K in Q2 2024. 551 funds tracked by Wall St. Rank hold HALO as of Q2 2025.

  • Procyon Advisors reported no remaining Halozyme position as of Q2 2025 after selling out during the quarter.
  • Procyon Advisors sold 4,625 Halozyme shares in Q2 2025, an estimated $295K.
  • Procyon Advisors first reported a position in Halozyme in Q2 2024 and held it in 4 quarters.
  • Procyon Advisors's Halozyme position peaked at $328K in Q2 2024.
  • 551 funds tracked by Wall St. Rank held Halozyme as of Q2 2025.

Based on Procyon Advisors's 13F filing for Q2 2025, filed 9 Jul 2025.